The nation of Zimbabwe has rejected a significant US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years over Washington's request for sensitive information.
This rejection came to light following a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa believed the arrangement was "skewed".
An official spokesman has since explained that the United States was seeking health data for scientific study and commercial gain but was unwilling to share the benefits from any future treatments.
"We are forced to start the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for more dialogue to find a agreement acceptable to all parties so the nation's critical HIV programme can be sustained.
Broader Context
Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a high court halted a related deal with the US following concerns were filed about the safety of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had managed aid for the US government, but Trump stated its spending was "inefficient" and his administration was seeking government-to-government agreements to enhance openness and responsibility.
As per statements, 16 nations in Africa have so far agreed to these new agreements, representing more than $18.3bn in new funding.
Specifics of the Declined Deal
This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this cooperation would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment via US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, without any equivalent promise of access to any scientific breakthroughs – like new medicines or tests – that might result from that provided information," his statement read.
"Put simply, our country would provide the raw materials for medical research without any assurance that the end products would be accessible to our people should a future pandemic emerge."
National Interest and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining frameworks previously set up via the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to manage potential pandemics.
"This framework is designed to ensure that when a nation contributes its data, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We are open to further dialogue with our American counterparts on how future collaboration might be designed in a way that respects the sovereignty and dignity of both nations."
Health Experts Reaction
A leading public health body said it understood the government's concerns, but urged that negotiations must proceed considering a large portion of the country's Aids initiatives depended on international support.
"If technical issues arise, including those involving data governance or implementation frameworks, these can often be addressed through detailed discussion and mutually agreed protections," the group added.
The situation highlights the continuing tensions between receiving crucial foreign assistance and protecting local interests in an increasingly data-driven world.